As of Mar 30
| +0.51 / +1.83%|
The 9 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 30.00, with a high estimate of 38.00 and a low estimate of 22.00. The median estimate represents a +5.67% increase from the last price of 28.39.
The current consensus among 9 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.